Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Cases and Controls on Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.

NCT01525199 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01525199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01525199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Cases and Controls on Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
November 30, 2013
Enrollment
450 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer, stage iiib/iv